Hexarelin vs Sermorelin
Research Verdict
Sermorelin is the stronger research reference for the stated comparison criteria. Sermorelin: FDA approved (withdrawn commercially 2008), adult RCT data (Walker 1997), GHRH mechanism.
Quick Answers
Which is better, Hexarelin or Sermorelin?
Sermorelin is the stronger research reference for the stated comparison criteria. Sermorelin: FDA approved (withdrawn commercially 2008), adult RCT data (Walker 1997), GHRH mechanism.
What is the key difference between Hexarelin and Sermorelin?
Sermorelin is GHRH(1-29) acting on pituitary GHRH receptors; hexarelin is a GHRP acting on GHS-R1a and CD36 receptors - different receptor mechanisms, and the combination would be complementary for GH stimulation.
Evidence Comparison
Sermorelin: FDA approved (withdrawn commercially 2008), adult RCT data (Walker 1997), GHRH mechanism. Hexarelin: no approval, GHRP mechanism with CD36 cardiovascular research. Sermorelin has the regulatory pedigree; hexarelin has the unique cardiovascular pharmacology.
Evidence Context Favoring Hexarelin
GHRP-class research with cardiovascular CD36 interest, or when ghrelin receptor mechanism is specifically studied.
Evidence Context Favoring Sermorelin
Research requiring FDA-reviewed human GH stimulation data via GHRH mechanism, or GHRH-class receptor studies.
Side-by-Side Snapshot
| Evidence grade | Hexarelin: Level C Sermorelin: Level B |
|---|---|
| Research status | Hexarelin: Phase 2 Sermorelin: Historical FDA Approval |
| Primary category | Hexarelin: Growth Hormone Sermorelin: Growth Hormone |
| Cited studies | Hexarelin: 2 Sermorelin: 2 |